Project
A phase III trial of marizomib in combination with standard
Automatically Closed · 2019 until 2019
Hess Dagmar
Type
Clinical Studies
Range
Multicentric, KSSG as main centre
Units
Status
Automatically Closed
Start Date
2019
End Date
2019
Financing
Industry
Study Design
Phase 1/2
Brief description/objective
Phase 1/2 Open-label Trial of Tinostamustine Conditioning and Autologous Stem Cell Transplantation for Salvage Treatment in Relapsed / Refractory Multiple Myeloma (TITANIUM 1)